A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection into muscle via syringe in healthy adults.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516575-32-00

Acronym

EPIN-IJS-1002

Enrollment

Registered

2024-12-05

Start date

2025-01-10

Completion date

2025-05-16

Last updated

2024-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic reactions (Type 1), idiopathic anaphylaxis or exercise-induced anaphylaxis, including anaphylaxis

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026